Mary Stawicki
Advertisement
Associate Director, regulatory affairs biopharm CMC, at GlaxoSmithKline
Articles by Mary Stawicki
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
How Engineered Exosomes Can Impact Targeted Therapies
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
